Furthermore, we showed that the pretreatment of cells with tiotropium or ISs from COPD patients treated with the anti-IL-17A Ab generated a band with lower levels of intensity in the TSLP promoter region compared with cells stimulated with rhIL-17A or ISs alone. This evidence concerns the gene IL17A and chronic obstructive pulmonary disease.